about
Detection of early impairment of coronary flow reserve in patients with systemic sclerosisThe arthritis-associated HLA-B*27:05 allele forms more cell surface B27 dimer and free heavy chain ligands for KIR3DL2 than HLA-B*27:09.Killer-cell immunoglobulin-like receptors (KIR) and HLA-class I heavy chains in ankylosing spondylitis.Calcinosis is associated with digital ulcers and osteoporosis in patients with systemic sclerosis: A Scleroderma Clinical Trials Consortium study.Associated autoimmune diseases in systemic sclerosis define a subset of patients with milder disease: results from 2 large cohorts of European Caucasian patients.Mapping and predicting mortality from systemic sclerosis.Functional disability and its predictors in systemic sclerosis: a study from the DeSScipher project within the EUSTAR group.HLA-E gene polymorphism associates with ankylosing spondylitis in Sardinia.Evaluation of cardiac functional abnormalities in systemic sclerosis by dobutamine stress echocardiography: a myocardial echostress scleroderma pattern.Absence of epicardial coronary stenosis in patients with systemic sclerosis with severe impairment of coronary flow reserve.Prediction of pulmonary hypertension related to systemic sclerosis by an index based on simple clinical observations.Hemarthrosis as acute presentation of acquired hemophilia in a patient with systemic lupus erythematosus: successful treatment and long-lasting remission.Joint and tendon involvement in systemic lupus erythematosus: an ultrasound study of hands and wrists in 108 patients.Susceptibility to ankylosing spondylitis but not disease outcome is influenced by the level of HLA-B27 expression, which shows moderate variability over timeA functional polymorphism of the vasoactive intestinal peptide receptor 1 gene correlates with the presence of HLA-B *2705 in SardiniaA sardinian patient with ankylosing spondylitis and HLA–B*2709 co-occurring with HLA–B*1403Two distinctive HLA haplotypes harbor the B27 alleles negatively or positively associated with ankylosing spondylitis in Sardinia: Implications for disease pathogenesisIncreased level of HLA-B27 expression in ankylosing spondylitis patients compared with healthy HLA-B27-positive subjects: a possible further susceptibility factor for the development of diseaseBleomycin-induced scleroderma: report of a case with a chronic course rather than the typical acute/subacute self-limiting formEffect of a single IV administration of L-propionylcarnitine on myocardial microcirculation assessed by coronary flow velocity reserve measurement in patients with systemic sclerosis: a pilot studyPrimary antiphospholipid syndrome with mesenteric venous thrombosis presenting with intestinal infarction: a case descriptionMultiple septic bursitis and spontaneous Achilles tendon tear in systemic lupus erythematosusCoronary atherosclerosis using computed tomography coronary angiography in patients with systemic sclerosis: comment on the article by Mok et alPost-streptococcal reactive arthritis associated with group G streptococcal pharyngitisThe growing role of cardiac magnetic resonance imaging in assessment and follow-up of pulmonary arterial hypertension associated with systemic sclerosisFamilial chilblain and late contractural arachnodactyly: a novel association?Vitamin D deficiency and insufficiency in 2 independent cohorts of patients with systemic sclerosisTwo different clinical subsets of lupus hepatitis exist. Mimicking primary autoimmune liver diseases or part of their spectrum?Does subclinical atherosclerosis really exist in systemic sclerosis? Comment on the article by Turiel et alOutcomes of patients with systemic sclerosis-associated polyarthritis and myopathy treated with tocilizumab or abatacept: a EUSTAR observational studyRituximab treatment for 'rhupus syndrome': clinical and power-Doppler ultrasonographic monitoring of response. A longitudinal pilot study
P50
Q35553128-DA8CF5E0-945E-4370-8C62-579054A0FE0BQ37234677-CE9DB00A-1C06-4D75-B97F-5812C147760FQ38266317-17B61594-07AB-4AAD-AB7E-CF6679B9EFCBQ39636957-A22A4255-B6EB-4149-B930-0C0BC46A85F0Q39917029-CE958E44-1D4C-4A67-8D2B-0441FE60EB9DQ40073055-9676B8F3-5145-46B8-9954-3281067207A1Q40469082-DD23D977-1C35-45F9-BC11-869151F4BC13Q41201765-CE3886BC-5DB9-4EA6-ADB8-57E2E83B7111Q42955132-0A91EB88-8DB6-4B4B-9172-7194B41EED93Q42956318-5A35BE15-138C-4279-A21E-93FD48C24C77Q44262313-CA7114C2-DA45-441B-BAF9-AFEEF2BEA763Q45880555-0A2644A5-1679-4869-9E82-4C9B7BF888FAQ53105511-FD649A0E-1D7B-493D-AF52-215EE1E4C40BQ62593782-95D25261-35DC-4EAA-A454-117F8A8FEF71Q62593836-4459278D-4F99-4A0E-8B2F-2E36B6DE1633Q62593849-6237382D-836C-49F9-AA33-8B2A73D351AEQ62593860-D17053C2-F591-4310-A992-30F5DD6FF77AQ62593865-15B0530D-F220-4BEC-BD28-E724FE12C247Q73090485-4DAC6A33-7AF2-4179-8112-0722006A2935Q80016101-9E05EF09-326E-4AD4-8945-FD0415B2C1F2Q80703993-6EE09144-8F5B-4D49-85DD-0E81467496CBQ82263277-2092EB40-4308-4F4B-A049-B4B84EBC14A8Q82623558-25A8F2E1-B196-4BC8-8980-9D7C6F6979F4Q82675432-EC705AE2-5F92-46CA-8A3D-7B39D5D5DDABQ83000932-E7C5D853-73A8-4A70-8606-810E4B926D59Q83149120-39D63306-6594-4DF4-B34C-BBEBAA3F0201Q84334303-D218E1B6-E93E-466A-9455-44FF1BF0C9FBQ84998640-0B5F2CF6-62F7-4984-84A1-35662BD4F84DQ85720078-FB2BCD30-F86C-4A52-8099-8AF6DF514366Q85740123-B8617FD9-1697-493A-8A43-27E3A68287C0Q86545771-C4DBA4BC-BFF6-4299-A4F3-0674AD9CB3CE
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0003-4289-2548
@en
name
Alessandra Vacca
@ast
Alessandra Vacca
@en
Alessandra Vacca
@es
Alessandra Vacca
@nl
type
label
Alessandra Vacca
@ast
Alessandra Vacca
@en
Alessandra Vacca
@es
Alessandra Vacca
@nl
prefLabel
Alessandra Vacca
@ast
Alessandra Vacca
@en
Alessandra Vacca
@es
Alessandra Vacca
@nl
P106
P1153
8080280100
P31
P496
0000-0003-4289-2548